MDR Vivacit-E Elevated Study

Enrolling by invitationOBSERVATIONAL
Enrollment

52

Participants

Timeline

Start Date

August 31, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Osteoarthritis (OA) of the HipAvascular Necrosis of Bone of HipProtrusio AcetabuliTraumatic Arthropathy-HipSlipped Capital Femoral EpiphysesFused HipFracture of PelvisDiastrophic Variant
Interventions
DEVICE

Vivacit-E Elevated Liners

Primary total hip arthroplasty

Trial Locations (1)

46635

South Bend Orthopaedics, South Bend

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Zimmer Biomet

INDUSTRY